Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
Dow
Healthtrust
Cerilliant
McKesson
Farmers Insurance
Queensland Health
UBS

Generated: May 26, 2018

DrugPatentWatch Database Preview

DRALZINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dralzine, and when can generic versions of Dralzine launch?

Dralzine is a drug marketed by Teva and is included in one NDA.

The generic ingredient in DRALZINE is hydralazine hydrochloride. There are twenty drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the hydralazine hydrochloride profile page.
Summary for DRALZINE
Drug patent expirations by year for DRALZINE
Medical Subject Heading (MeSH) Categories for DRALZINE
Synonyms for DRALZINE
(1E)-1-hydrazinylidene-1,2-dihydrophthalazine
(1Z)-1-hydrazinylidene-2H-phthalazine hydrochloride
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
(E)-1-Hydrazono-1,2-dihydrophthalazine
(Z)-1-Hydrazono-1,2-dihydrophthalazine hydrochloride
[2H-Phthalazin-(1Z)-Ylidene]-Hydrazine Hydrochloride
1-(Phthalazin-1-yl)hydrazine
1-Hydrazinophthalazine
1-hydrazinophthalazine HCL
1-Hydrazinophthalazine hydrochloride
1-Hydrazinophthalazine monohydrochloride
1-hydrazinyl-Phthalazine hydrochloride
1-hydrazinylidene-1,2-dihydrophthalazine
1-Hydrazinylphthalazine
1-Hydrazinylphthalazine hydrochloride
1-Hydrazinylphthalazinehydrochloride
1-Hydrazono-1,2-dihydrophthalazine
1-hydrazonophthalazine
1-Phthalazinylhydrazine
1(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone hydrazone #
1(2H)-Phthalazinone hydrazone hydrochloride
1(2H)-Phthalazinone, hydrazone
1(2H)-Phthalazinone, hydrazone, (E)- (9CI)
1(2H)-Phthalazinone, hydrazone, hydrochloride
1(2H)-Phthalazinone, hydrazone, monohydrochloride
1(2H)-Phthalazinone, hydrochloride
1(2H)-Phthalazinone, monohydrochloride
1044569-46-1
26NAK24LS8
304-20-1
304-20-1 (mono-hydrochloride)
3B1-006470
48242-EP2272832A1
48242-EP2272841A1
48242-EP2301936A1
48242-EP2311494A1
5-25-17-00412 (Beilstein Handbook Reference)
59275-69-3
599H497
6-Hydralazine
81411-23-6
86-54-4
8816AB
AB00053483_03
AB0062919
AB01274815_02
AB01274815-01
AB2000658
AC-18050
AC1L1GDN
AC1L1SV4
AC1Q3COW
AC1Q3DGV
AC1Q4UY1
ACMC-209hfr
Aiselazine
AJ-61683
AK-51529
AK101156
AK310880
AK499698
AKOS000122609
AKOS008968535
AKOS025116605
AKOS028109138
AKOS028109609
ALBB-023848
AN-1061
AN-42348
ANW-26869
ANW-60429
AOB5342
Apresolin
Apresoline
Apresoline (TN)
Apresoline hydrochloride
Apressin
Apressin (pharmaceutical)
Apressoline
Aprezolin
ARONIS27196
BA 5968
BDBM81461
BPI-103
BRD-K82103381-003-03-7
BRN 0132615
BSPBio_002130
C 5968
C-5068
C-5968
C07040
C8H8N4
C8H8N4.HCl
CAS_86-54-4
CAS-304-20-1
CCG-204682
CCG-40185
CCRIS 5385
CHEBI:31672
CHEBI:5775
CHEMBL276832
CHEMBL542541
Ciba 5968
CJ-13950
CS-2578
CTK1G9430
CTK3E4473
CTK8B1415
D01302
D08044
D0K1XK
DB01275
DivK1c_000117
DSSTox_CID_24645
DSSTox_GSID_44645
DSSTox_RID_80373
DTXSID1044645
DTXSID4023129
EC-000.1838
EINECS 201-680-3
EN300-03637
Epitope ID:137349
EU-0100593
FT-0669282
FT-0669283
GTPL7326
H 1753
HE034468
HE042444
HE177861
HE177864
Hidral
Hidral (TN)
Hidralazin
Hidralazina
Hidralazina [INN-Spanish]
Hidralazina [Spanish]
Hipoftalin
HLZ
HMS1568B19
HMS1920D17
HY-B0464
Hydralazin
hydralazine
Hydralazine (hydrochloride)
Hydralazine (INN)
Hydralazine [INN:BAN]
Hydralazine chloride
HYDRALAZINE HCL
HYDRALAZINE HYDROCHLORIDE
Hydralazine hydrochloride (JP17/USP)
Hydralazine hydrochloride [JAN]
Hydralazine mono-Hydrochloride
Hydralazine monohydrochloride
Hydralazinhydrochlorid
Hydralazinum
Hydralazinum [INN-Latin]
Hydrallazin
Hydrallazine
Hydrallazine hydrochloride
Hydrazinophthalazine
Hydrazone 1(2H)-phthalazinone
Hyperazin
Hyperex
Hypophthalin
I14-85667
IDI1_000117
Idralazina
Idralazina [DCIT]
Idralazina [Italian]
InChI=1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)
KB-12604
KBio1_000117
KBio2_001355
KBio2_003923
KBio2_006491
KBio3_001350
KBioGR_000349
KBioSS_001355
KS-00000XOB
KS-000048OG
KSC911I1L
Lopac-H-1753
Lopac0_000593
Lopress
LP00593
LS-109171
LS-109173
MCULE-9226495081
MCULE-9301781478
MolPort-000-876-738
MolPort-003-666-202
MolPort-003-941-613
mono-HYDRAZINOPHTHALAZINE HCl
NCGC00015501-01
NCGC00015501-02
NCGC00015501-03
NCGC00015501-04
NCGC00015501-05
NCGC00015501-06
NCGC00015501-07
NCGC00015501-09
NCGC00093972-01
NCGC00093972-02
NCGC00093972-03
NCGC00093972-04
NCGC00162199-01
NCGC00256719-01
NCGC00261278-01
NCIOpen2_001484
NE41773
NINDS_000117
NSC 126699
NSC_3637
NSC-126699
NSC-757058
NSC-89394
NSC126699
NSC757058
NSC89394
Oprea1_207681
Oprea1_416878
Pharmakon1600-01500334
phthalazin-1-ylhydrazine
phthalazin-1-ylhydrazine hydrochloride
Phthalazine, 1-hydrazino-
phthalazine, 1-hydrazino-, hydrochloride
Phthalazine, monohydrochloride
Phthalazinone hydrazone monohydrochloride
Phthalazinone, monohydrochloride
phthalazinylhydrazine
phthalazone hydrazone
Praparat 5968
Prestwick_610
Prestwick0_000169
Prestwick1_000169
Prestwick2_000169
Q-201208
R2262
RPTUSVTUFVMDQK-UHFFFAOYSA-
RPTUSVTUFVMDQK-UHFFFAOYSA-N
RTR-013075
s2562
SBB000358
SBB071765
SBI-0050575.P004
SC-16076
SCHEMBL36271
SCHEMBL7810
Slow-Apresolin
SPBio_000977
SPBio_001958
Spectrum_000875
SPECTRUM1500334
Spectrum2_000969
Spectrum3_000455
Spectrum4_000005
Spectrum5_000822
SR-01000075903
SR-01000075903-1
ST45026967
ST50512087
ST50825409
STK246900
TC-149174
Tox21_110163
Tox21_110163_1
Tox21_302496
Tox21_500593
TR-013075
UNII-26NAK24LS8
WLN: T66 CNNJ BMZ
WLN: T66 CNNJ BMZ & GH
Z57980178
ZINC12360535
ZUXNZUWOTSUBMN-UHFFFAOYSA-N

US Patents and Regulatory Information for DRALZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva DRALZINE hydralazine hydrochloride TABLET;ORAL 084301-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
Fish and Richardson
Moodys
US Army
Citi
Teva
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.